Literature DB >> 34880495

Structure of pathological TDP-43 filaments from ALS with FTLD.

Diana Arseni1, Masato Hasegawa2, Alexey G Murzin1, Fuyuki Kametani2, Makoto Arai3, Mari Yoshida4, Benjamin Ryskeldi-Falcon5.   

Abstract

The abnormal aggregation of TAR DNA-binding protein 43 kDa (TDP-43) in neurons and glia is the defining pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and multiple forms of frontotemporal lobar degeneration (FTLD)1,2. It is also common in other diseases, including Alzheimer's and Parkinson's. No disease-modifying therapies exist for these conditions and early diagnosis is not possible. The structures of pathological TDP-43 aggregates are unknown. Here we used cryo-electron microscopy to determine the structures of aggregated TDP-43 in the frontal and motor cortices of an individual who had ALS with FTLD and from the frontal cortex of a second individual with the same diagnosis. An identical amyloid-like filament structure comprising a single protofilament was found in both brain regions and individuals. The ordered filament core spans residues 282-360 in the TDP-43 low-complexity domain and adopts a previously undescribed double-spiral-shaped fold, which shows no similarity to those of TDP-43 filaments formed in vitro3,4. An abundance of glycine and neutral polar residues facilitates numerous turns and restricts β-strand length, which results in an absence of β-sheet stacking that is associated with cross-β amyloid structure. An uneven distribution of residues gives rise to structurally and chemically distinct surfaces that face external densities and suggest possible ligand-binding sites. This work enhances our understanding of the molecular pathogenesis of ALS and FTLD and informs the development of diagnostic and therapeutic agents that target aggregated TDP-43.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34880495      PMCID: PMC7612255          DOI: 10.1038/s41586-021-04199-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  59 in total

1.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

2.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

3.  Prion-like properties of pathological TDP-43 aggregates from diseased brains.

Authors:  Takashi Nonaka; Masami Masuda-Suzukake; Tetsuaki Arai; Yoko Hasegawa; Hiroyasu Akatsu; Tomokazu Obi; Mari Yoshida; Shigeo Murayama; David M A Mann; Haruhiko Akiyama; Masato Hasegawa
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

4.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

Review 5.  Cognitive impairment in amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Niall P Pender; Orla Hardiman
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

6.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Paul N Valdmanis; Patrick Dion; Dan Spiegelman; Brendan J McConkey; Christine Vande Velde; Jean-Pierre Bouchard; Lucette Lacomblez; Ksenia Pochigaeva; Francois Salachas; Pierre-Francois Pradat; William Camu; Vincent Meininger; Nicolas Dupre; Guy A Rouleau
Journal:  Nat Genet       Date:  2008-03-30       Impact factor: 38.330

7.  TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.

Authors:  Vivianna M Van Deerlin; James B Leverenz; Lynn M Bekris; Thomas D Bird; Wuxing Yuan; Lauren B Elman; Dana Clay; Elisabeth McCarty Wood; Alice S Chen-Plotkin; Maria Martinez-Lage; Ellen Steinbart; Leo McCluskey; Murray Grossman; Manuela Neumann; I-Lin Wu; Wei-Shiung Yang; Robert Kalb; Douglas R Galasko; Thomas J Montine; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg; Chang-En Yu
Journal:  Lancet Neurol       Date:  2008-04-07       Impact factor: 44.182

8.  Cryo-EM structures of four polymorphic TDP-43 amyloid cores.

Authors:  Qin Cao; David R Boyer; Michael R Sawaya; Peng Ge; David S Eisenberg
Journal:  Nat Struct Mol Biol       Date:  2019-06-24       Impact factor: 15.369

9.  Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43.

Authors:  Qiuye Li; W Michael Babinchak; Witold K Surewicz
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

10.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

View more
  23 in total

Review 1.  Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers.

Authors:  Michael Tran Duong; David A Wolk
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-03       Impact factor: 6.030

Review 2.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

3.  Recognition of the TDP-43 nuclear localization signal by importin α1/β.

Authors:  Steven G Doll; Hamed Meshkin; Alexander J Bryer; Fenglin Li; Ying-Hui Ko; Ravi K Lokareddy; Richard E Gillilan; Kushol Gupta; Juan R Perilla; Gino Cingolani
Journal:  Cell Rep       Date:  2022-06-28       Impact factor: 9.995

4.  Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.

Authors:  Yi Xiao Jiang; Qin Cao; Michael R Sawaya; Romany Abskharon; Peng Ge; Michael DeTure; Dennis W Dickson; Janine Y Fu; Rachel R Ogorzalek Loo; Joseph A Loo; David S Eisenberg
Journal:  Nature       Date:  2022-03-28       Impact factor: 69.504

5.  Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.

Authors:  Andrew Chang; Xinyu Xiang; Jing Wang; Carolyn Lee; Tamta Arakhamia; Marija Simjanoska; Chi Wang; Yari Carlomagno; Guoan Zhang; Shikhar Dhingra; Manon Thierry; Jolien Perneel; Bavo Heeman; Lauren M Forgrave; Michael DeTure; Mari L DeMarco; Casey N Cook; Rosa Rademakers; Dennis W Dickson; Leonard Petrucelli; Michael H B Stowell; Ian R A Mackenzie; Anthony W P Fitzpatrick
Journal:  Cell       Date:  2022-03-04       Impact factor: 66.850

6.  Aggregates of TDP-43 protein spiral into view.

Authors:  Hana M Odeh; James Shorter
Journal:  Nature       Date:  2022-01       Impact factor: 69.504

7.  An unexpected protein aggregate in diseased and ageing brains.

Authors:  Hideyuki Takahashi; Stephen M Strittmatter
Journal:  Nature       Date:  2022-05       Impact factor: 69.504

8.  Head-to-Head Comparison of Tau-PET Radioligands for Imaging TDP-43 in Post-Mortem ALS Brain.

Authors:  Ashley C Knight; Christopher D Morrone; Cassis Varlow; Wai Haung Yu; Paul McQuade; Neil Vasdev
Journal:  Mol Imaging Biol       Date:  2022-10-18       Impact factor: 3.484

Review 9.  Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases.

Authors:  Jenny L Carey; Lin Guo
Journal:  Front Mol Biosci       Date:  2022-02-02

10.  Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy.

Authors:  Sofia Lövestam; Fujiet Adrian Koh; Bart van Knippenberg; Abhay Kotecha; Alexey G Murzin; Michel Goedert; Sjors H W Scheres
Journal:  Elife       Date:  2022-03-04       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.